Search Results 151-160 of 18142 for monoclonal antibody

  1. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... At least 6 weeks since prior monoclonal antibody therapy; At least 7 ...

  2. Oncology (Medical) - Clinical trials

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, may block ...

  3. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  4. Small Bowel Cancer Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as pembrolizumab, may ... Ramucirumab is a monoclonal antibody that attaches to and inhibits a molecule called VEGFR-2.

  5. Mayo Clinic Study Suggests Two is Better Than One When Battling Agressive Lymphoma

    When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse ...

  6. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, may block ...

  7. A Study In Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab Vs. Observation - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of ... No history of severe hypersensitivity to a monoclonal antibody. Signed ...

  8. Diffuse Large B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...

  9. LS138D, Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as rituximab, may find cancer cells and help kill them. Radioactive substances linked to monoclonal antibodies can bind to ...

  10. Belimumab (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Belimumab injection is used to treat active, autoantibody ... It is a monoclonal antibody that changes the immune system to help control lupus symptoms.